If you take tirzepatide and use CPAP, weight change or less snoring may prompt a question before the honeymoon: do you still need the machine? Bring that question to your sleep clinician before changing treatment or leaving equipment at home. The answer needs your diagnosis, current response and a follow-up plan.
Describe the sleep problem before choosing a treatment
The National Heart, Lung, and Blood Institute lists breathing pauses, gasping and frequent loud snoring as possible sleep-apnea symptoms. Daytime sleepiness, dry mouth, headaches, fatigue, insomnia and waking to urinate can also occur. It notes that fatigue, headache and insomnia are more common symptoms in women. [2] Those symptoms warrant discussion rather than an assumption that wedding planning explains them.
Write down what you notice, how often it happens and whether a partner has observed breathing pauses. Include any near-sleep episodes during daytime activities, your usual sleep schedule and medicines or supplements you take. A partner's report can be useful, but neither a description nor a recording establishes the diagnosis.
If you have already had a sleep study, bring its report and date. Ask the clinician to explain the type and severity of sleep apnea and the result that will guide treatment. If you have not been assessed, ask which evaluation is appropriate rather than starting with a request for a particular prescription.
What the tirzepatide studies measured
The FDA based its OSA approval on two randomized, double-blind, placebo-controlled studies involving 469 adults without type 2 diabetes. One enrolled people using positive airway pressure, or PAP; the other enrolled people unable or unwilling to use PAP. Treatment lasted 52 weeks. [1]
The published SURMOUNT-OSA report measured the apnea-hypopnea index, or AHI: the number of apnea and hypopnea events per hour of sleep. At week 52, the estimated average AHI reduction in the trial without PAP was 25.3 events per hour with tirzepatide versus 5.3 with placebo. In the trial with PAP users, the reductions were 29.3 versus 5.5 events per hour. Eli Lilly funded the studies. [3]
Those are reductions in events per hour, not additional hours of sleep or a count of people cured. The two trials enrolled different groups; their results cannot establish that adding or removing PAP caused the difference between the trials. The studies also do not predict your response by the wedding date.
The American Academy of Sleep Medicine points out that factors such as jaw and upper-airway structure can contribute to OSA. Its statement says Zepbound may reduce severity without curing the condition, and some people may benefit from combined treatment. [4] Ask which factors matter in your case.
Why the study does not supply a CPAP stopping date
The August 2026 Zepbound prescribing information states that the OSA studies did not evaluate when or whether PAP could appropriately be discontinued in people previously using it consistently. In the PAP-user study, participants suspended PAP for seven days before the primary-endpoint assessment. [5] That research procedure is not an instruction to interrupt your own treatment.
Ask what evidence your clinician would need before changing PAP. Bring the machine's usage and efficacy information if the clinic requests it, together with your symptoms and any problems using the equipment. Describe mask leaks, discomfort or interrupted use accurately so the team can interpret the information.
NHLBI advises using prescribed PAP for all sleep, including naps, and bringing the device when traveling. It recommends discussing a leaking or poorly fitting mask, sleep difficulty, dry mouth or nasal symptoms with the provider. [6] Address those problems before travel rather than deciding that an uncomfortable mask is evidence the treatment is unnecessary.
Make reassessment specific
AASM's 2021 follow-up testing guidance says repeat laboratory or home sleep testing may be used after clinically significant weight gain or loss. It recommends follow-up testing to assess response to non-PAP treatments. It also says routine repeat testing is not recommended for asymptomatic people doing well on PAP, while persistent or recurrent symptoms can justify reassessment despite good adherence. [7]
Ask whether you need testing now, later or only if particular changes occur. Record who orders it, what you should use while waiting and who will explain the results. If testing involves a temporary treatment change, obtain individual instructions from the sleep team rather than copying a study protocol.
Give the clinic your wedding and travel dates so appointments and results can be coordinated. If assessment cannot be completed before departure, ask for a clear interim plan. A booked honeymoon does not determine whether OSA is controlled.
Review the medicine with the prescriber
The Zepbound label carries a boxed warning about thyroid C-cell tumors seen in rats; the human relevance is unknown. It is contraindicated with a personal or family history of medullary thyroid carcinoma, MEN2 or a previous serious hypersensitivity reaction to tirzepatide or its ingredients. It also includes warnings about severe gastrointestinal reactions and other risks. [5] Your prescriber needs the relevant history when considering treatment.
Bring your complete medicine list and report adverse effects, pregnancy intentions and any difficulty eating or drinking. Ask how the sleep clinician and prescribing clinician will communicate. Avoid changing doses to meet a sleep-study appointment or wedding deadline without their directions.
If you already take a GLP-1 medicine, confirm the exact product and indication during the review. The FDA approval discussed here is for Zepbound and the specified OSA population. [1] It should not be read as approval of every medicine in the broader drug class for every form of sleep apnea.
Carry the agreed plan into wedding week
Arrange the overnight setup at the preparation hotel and honeymoon accommodation. Decide who carries the equipment, check its instructions and confirm what the supplier recommends for the trip. The site's CPAP travel guide covers transport and power questions in more detail.
Tell the care team about any planned procedure involving sedation or anesthesia. NHLBI advises informing clinicians about sleep apnea when surgery or postoperative pain medicines are involved. It also advises against driving when tired or sleepy. [6] Arrange another driver if sleepiness affects a late-night wedding transfer or a honeymoon rental-car trip.
Chapter 15 of Bridegenic treats the wedding as part of continuing care. Keep the follow-up appointment and treatment instructions available after the event, especially if symptoms or weight are still changing.
Physical Book (No Download)
Bridegenic: The Glow-Up Guide for Brides on GLP-1s
$12.95 + Free Shipping
Order NowThis article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Talk with your prescriber, pharmacist or dermatologist about decisions for your care.
Read next
Honeymoon & BeyondHoneymoon CPAP Travel: Flights, Batteries and Bedside Power→Wedding WeekSleep During Wedding Week: A Schedule, a Handoff and a Backup Plan→Sources
- FDA Approves First Medication for Obstructive Sleep Apnea, December 20, 2024U.S. Food and Drug Administration↩ Back to text
- Sleep Apnea Symptoms, January 9, 2025National Heart, Lung, and Blood Institute↩ Back to text
- Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity, 2024Malhotra and colleagues, New England Journal of Medicine↩ Back to text
- Zepbound Approval for Sleep Apnea: AASM Statement, December 23, 2024American Academy of Sleep Medicine↩ Back to text
- Zepbound U.S. Prescribing Information, revised August 2026Eli Lilly and Company↩ Back to text
- Sleep Apnea: Living With, January 9, 2025National Heart, Lung, and Blood Institute↩ Back to text
- Use of Polysomnography and Home Sleep Apnea Tests for Longitudinal Management, 2021Caples and colleagues, American Academy of Sleep Medicine↩ Back to text
